Phototheranostic Zinc Porphyrin Nanoparticles Triggered by an 808 nm Laser: NIR-II Fluorescence/Photoacoustic Imaging-Guided Combined Photothermal/Photodynamic/NO Therapy
Bioconjugate Chemistry · 2025
DOI: 10.1021/acs.bioconjchem.5c00086 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioconjugate Chemistry, 2025. Verfasst von Hongyu Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy and Institute of Pharmacy, Medical Imaging Key Laboratory of Sichuan Province, Thyroid and Breast Surgery, North Sichuan Medical C…. Hauptthemen laut MEDLINE: Metal Nanoparticles, Phototherapy, Combined Modality Therapy, Lithotripsy, Laser. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Basic Research Programs of Sichuan Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Single-wavelength lasers that trigger intelligently designed multifunctional theranostic nanoplatforms are urgently needed for early cancer diagnosis and imaging-guided therapy. In this study, a novel zinc porphyrin, Por-TR, was fabricated by incorporating thiophene as a donor and introducing electron acceptors on both sides to expand the conjugation. The presence of multiple flexible chains in the molecular structure of Por-TR inhibits π-π stacking, which allows it to form J nanoaggregates when coassembled with DSPE-PEG2000, demonstrating maximum absorption at approximately 808 nm. These Por-TR NPs provide NIR-II fluorescence/PA dual-modal signals for imaging and serve as a combined PTT/PDT therapeutic agent, making them a suitable multifunctional theranostic nanoplatform. To further improve their therapeutic effects, we embedded a thermosensitive NO donor, BNN6, in the Por-TR nanosystem to achieve combined PDT/PTT/NO therapy. Intravenous injection of Por-TR-NO NPs into 4T1 tumor-bearing mice enabled the accurate observation of tumor location via NIR-II fluorescence/PA dual-modal imaging. In vivo therapy results show that the Por-TR-NO NPs exhibited remarkable antitumor efficacy in combined PTT/PDT/NO therapy, which was triggered by an 808 nm laser. Overall, this nanoplatform offers a versatile approach to cancer diagnosis and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Pharmacy and Institute of Pharmacy, Medical Imaging Key Laboratory of Sichuan Province, Thyroid and Breast Surgery, North Sichuan Medical College, Affiliated Hospital of North Sichuan Medical College, Sichuan…
- Physical-Technical Institute, Uzbekistan Academy of Sciences, 100084 Tashkent, Uzbekistan.
- Institute of Electrical Engineering, Chinese Academy of Sciences, Beijing 100190, China.
- Shandong Provincial Key Laboratory for Science of Material Creation and Energy Conversion, Institute of Frontier Chemistry, School of Chemistry and Chemical Engineering, Shandong University, Qingdao 266237, P.R. China.
Förderung
- Basic Research Programs of Sichuan Province
- National Natural Science Foundation of China
Zitieren
APA
Chen, H., Zhao, X., Halimov, A., Fu, M., Tu, J., Liu, H., Xu, H., & Liu, J. (2025). Phototheranostic Zinc Porphyrin Nanoparticles Triggered by an 808 nm Laser: NIR-II Fluorescence/Photoacoustic Imaging-Guided Combined Photothermal/Photodynamic/NO Therapy. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.5c00086
Vancouver
Chen H, Zhao X, Halimov A, Fu M, Tu J, Liu H, et al. Phototheranostic Zinc Porphyrin Nanoparticles Triggered by an 808 nm Laser: NIR-II Fluorescence/Photoacoustic Imaging-Guided Combined Photothermal/Photodynamic/NO Therapy. Bioconjugate Chemistry. 2025. doi:10.1021/acs.bioconjchem.5c00086
BibTeX
@article{Chen2025,
author = {Chen, Hongyu and Zhao, Xiaobo and Halimov, Akbar and Fu, Mingkai and Tu, Jing and Liu, Hui and Xu, Huajun and Liu, Jun},
title = {Phototheranostic Zinc Porphyrin Nanoparticles Triggered by an 808 nm Laser: NIR-II Fluorescence/Photoacoustic Imaging-Guided Combined Photothermal/Photodynamic/NO Therapy},
journal = {Bioconjugate Chemistry},
year = {2025},
doi = {10.1021/acs.bioconjchem.5c00086}
}
EUVIMED